Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05818683
- Conditions
- Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Start Midwest Grand Rapids, Michigan, United States
- Washington University School Of Medicine St Louis, Missouri, United States
- Perlmutter Cancer Center at NYU Langone Brooklyn Brooklyn, New York, United States